Literature DB >> 17348653

Hybrid peptide design. Hydrogen bonded conformations in peptides containing the stereochemically constrained gamma-amino acid residue, gabapentin.

Prema G Vasudev1, Kuppanna Ananda, Sunanda Chatterjee, Subrayashastry Aravinda, Narayanaswamy Shamala, Padmanabhan Balaram.   

Abstract

The crystal structure of 12 peptides containing the conformationally constrained 1-(aminomethyl)cyclohexaneacetic acid, gabapentin (Gpn), are reported. In all the 39 Gpn residues conformationally characterized so far, the torsion angles about the Calpha-Cbeta and Cbeta-Cgamma bonds are restricted to the gauche conformation (+/-60 degrees ). The Gpn residue is constrained to adopt folded conformations resulting in the formation of intramolecularly hydrogen-bonded structures even in short peptides. The peptides Boc-Ac6c-Gpn-OMe 1 and Boc-Gpn-Aib-Gpn-Aib-OMe 2 provide examples of C7 conformation; peptides Boc-Gpn-Aib-OH 3, Boc-Ac6c-Gpn-OH 4, Boc-Val-Pro-Gpn-OH 5, Piv-Pro-Gpn-Val-OMe 6, and Boc-Gpn-Gpn-Leu-OMe 7 provide examples of C9 conformation; peptide Boc-Ala-Aib-Gpn-Aib-Ala-OMe 8 provides an example of C12 conformation and peptides Boc-betaLeu-Gpn-Val-OMe 9 and Boc-betaPhe-Gpn-Phe-OMe 10 provide examples of C13 conformation. Gpn peptides provide examples of backbone expanded mimetics for canonical alpha-peptide turns like the gamma (C7) and the beta (C10) turns. The hybrid betagamma sequences provide an example of a mimetic of the C13 alpha-turn formed by three contiguous alpha-amino acid residues. Two examples of folded tripeptide structures, Boc-Gpn-betaPhe-Leu-OMe 11 and Boc-Aib-Gpn-betaPhg-NHMe 12, lacking internal hydrogen bonds are also presented. An analysis of available Gpn residue conformations provides the basis for future design of folded hybrid peptides.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17348653     DOI: 10.1021/ja068910p

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  8 in total

Review 1.  Foldamers as versatile frameworks for the design and evolution of function.

Authors:  Catherine M Goodman; Sungwook Choi; Scott Shandler; William F DeGrado
Journal:  Nat Chem Biol       Date:  2007-05       Impact factor: 15.040

2.  Enantioselective organocatalytic Michael addition of aldehydes to nitroethylene: efficient access to gamma2-amino acids.

Authors:  Yonggui Chi; Li Guo; Nathan A Kopf; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2008-04-04       Impact factor: 15.419

3.  Helix formation in preorganized beta/gamma-peptide foldamers: hydrogen-bond analogy to the alpha-helix without alpha-amino acid residues.

Authors:  Li Guo; Aaron M Almeida; Weicheng Zhang; Andrew G Reidenbach; Soo Hyuk Choi; Ilia A Guzei; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2010-06-16       Impact factor: 15.419

4.  Orthogonal Halogen-Bonding-Driven 3D Supramolecular Assembly of Right-Handed Synthetic Helical Peptides.

Authors:  Peng Teng; Geoffrey M Gray; Mengmeng Zheng; Sylvia Singh; Xiaopeng Li; Lukasz Wojtas; Arjan van der Vaart; Jianfeng Cai
Journal:  Angew Chem Int Ed Engl       Date:  2019-04-30       Impact factor: 15.336

5.  Impact of γ-Amino Acid Residue Preorganization on α/γ-Peptide Foldamer Helicity in Aqueous Solution.

Authors:  Brian F Fisher; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2016-08-16       Impact factor: 15.419

6.  Stereospecific synthesis of conformationally constrained gamma-amino acids: new foldamer building blocks that support helical secondary structure.

Authors:  Li Guo; Yonggui Chi; Aaron M Almeida; Ilia A Guzei; Brian K Parker; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2009-11-11       Impact factor: 15.419

Review 7.  Control of asymmetry in the radical addition approach to chiral amine synthesis.

Authors:  Gregory K Friestad
Journal:  Top Curr Chem       Date:  2014

8.  New preorganized γ-amino acids as foldamer building blocks.

Authors:  Li Guo; Weicheng Zhang; Ilia A Guzei; Lara C Spencer; Samuel H Gellman
Journal:  Org Lett       Date:  2012-05-08       Impact factor: 6.005

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.